In the absence of TPD cases with the mild Acb tau pathology, it remains to be determined whether the difference is attributable to the distinct pathomechanisms between AD and TPD or to the variable vulnerability of different neuronal cell types. This evidence concerns the gene MAPT and Alzheimer disease.